Flavia Ejzykowicz
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
-
- Diabetes Treatment and Management
- Diabetes Management and Research
Papers in
-
- Renal cell carcinoma treatment 17
- Lung Cancer Treatments and Mutations 4
-
- Economic and Financial Impacts of Cancer 19
- Health Systems, Economic Evaluations, Quality of Life 15
- Co-authors
- Thomas Burke (3 shared papers)Ralph P. Insinga (2 shared papers)Josephine Feliciano (2 shared papers)S Traoré (1 shared paper)David J. Vanness (1 shared paper)Kristel Vandormael (1 shared paper)David Cella (10 shared papers)Melissa Hamilton (8 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)Value in Health (10 papers)Annals of Oncology (3 papers)Journal of Medical Economics (2 papers)Clinical Therapeutics (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Flavia Ejzykowicz
33 papers receiving 363 citations
Peers
Comparison fields: 5 of 53
- Oncology 173
- Endocrinology, Diabetes and Metabolism 100
- Pulmonary and Respiratory Medicine 158
- Cancer Research 47
- Economics and Econometrics 65
Countries citing papers authored by Flavia Ejzykowicz
This map shows the geographic impact of Flavia Ejzykowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flavia Ejzykowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flavia Ejzykowicz more than expected).
Fields of papers citing papers by Flavia Ejzykowicz
This network shows the impact of papers produced by Flavia Ejzykowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flavia Ejzykowicz. The network helps show where Flavia Ejzykowicz may publish in the future.
Co-authors
The 25 scholars most cited alongside Flavia Ejzykowicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 67 | |
| 2 | 2019 | 61 | |
| 3 | 2022 | 60 | |
| 4 | 2019 | 48 | |
| 5 | 2024 | 20 | |
| 6 | 2019 | 20 | |
| 7 | 2015 | 13 | |
| 8 | 2017 | 13 | |
| 9 | 2021 | 9 | |
| 10 | 2018 | 7 | |
| 11 | 2013 | 7 | |
| 12 | 2024 | 5 | |
| 13 | 2021 | 4 | |
| 14 | 2020 | 3 | |
| 15 | 2019 | 3 | |
| 16 | 2021 | 3 | |
| 17 | 2018 | 3 | |
| 18 | 2023 | 3 | |
| 19 | 2021 | 3 | |
| 20 | 2023 | 2 |
About Flavia Ejzykowicz
Flavia Ejzykowicz is a scholar working on Pulmonary and Respiratory Medicine, Economics and Econometrics, Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism, having authored 42 papers that have together received 367 indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (19 papers), Renal cell carcinoma treatment (17 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers), Cancer Immunotherapy and Biomarkers (10 papers), Diabetes Treatment and Management (6 papers), Diabetes Management and Research (5 papers), Renal and related cancers (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Oncology (173 citations), Endocrinology, Diabetes and Metabolism (100 citations), Pulmonary and Respiratory Medicine (158 citations), Cancer Research (47 citations) and Economics and Econometrics (65 citations). Flavia Ejzykowicz has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Thomas Burke, Ralph P. Insinga, Josephine Feliciano, S Traoré, David J. Vanness, Kristel Vandormael, David Cella, Melissa Hamilton, Swapnil Rajpathak and Cristina Ivanescu. Their work appears in journals such as Journal of Clinical Oncology, Value in Health, Annals of Oncology, Journal of Medical Economics and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.